The Valley Desk

NCT06430385 · Interventional trial

ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov